Journal Mobile Options
Table of Contents
Vol. 27, No. 2, 2010
Issue release date: March 2010
Fetal Diagn Ther 2010;27:101–105

Tricuspid Valve Dysplasia with Severe Tricuspid Regurgitation: Fetal Pulmonary Artery Size Predicts Lung Viability in the Presence of Small Lung Volumes

Nathan A.T. · Marino B.S. · Dominguez T. · Tabbutt S. · Nicolson S. · Donaghue D.D. · Spray T.L. · Rychik J.
Divisions of aCardiac Anesthesia, bCardiothoracic Surgery, cCardiology and dCritical Care Medicine, and eFetal Heart Program, Cardiac Center, Children’s Hospital of Philadelphia, and University of Pennsylvania, Philadelphia, Pa., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Congenital tricuspid valve disease (Ebstein’s anomaly, tricuspid valve dysplasia) with severe tricuspid regurgitation and cardiomegaly is associated with poor prognosis. Fetal echocardiography can accurately measure right atrial enlargement, which is associated with a poor prognosis in the fetus with tricuspid valve disease. Fetal lung volumetric assessments have been used in an attempt to predict viability of fetuses using ultrasonogram and prenatal MRI. We describe a fetus with tricuspid dysplasia, severe tricuspid regurgitation, right atrial enlargement and markedly reduced lung volumes. The early gestational onset of cardiomegaly with bilateral lung compression raised the possibility of severe lung hypoplasia with decreased broncho-alveolar development. Use of fetal echocardiography with measurement of pulmonary artery size combined with prenatal MRI scanning of lung volumes resulted in an improved understanding of this anomaly and directed the management strategy towards a successful Fontan circulation.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Hornberger LK, Sahn DJ, Kleinman CS, Copel JA, Reed KL: Tricuspid valve disease with significant tricuspid insufficiency in the fetus: diagnosis and outcome. J Am Coll Cardiol 1991;17:167–173.
  2. Sahn DJ, Heldt GP, Reed KL, Kleinman C, Meijboom EJ: Fetal heart disease with cardiomegaly may be associated with lung hypoplasia as a determinant of poor prognosis. J Am Coll Cardiol 1988;11:9A.

    External Resources

  3. Sharland GK, Chita SK, Allan LD: Tricuspid valve dysplasia or displacement in intrauterine life. J Am Coll Cardiol 1991;17:944–949.
  4. Lang D, Oberhoffer R, Cook A, Sharland G, Allan L, Fagg N, Anderson RH: Pathologic spectrum of malformation of the tricuspid valve in prenatal and neonatal life. J Am Coll Cardiol 1991;17:1161–1167.
  5. Oberhoffer R, Cook AC, Lang D, Sharland G, Allan LD, Fagg NL, Anderson RH: Correlation between echocardiographic and morphological investigations of lesions of the tricuspid valve diagnosed during fetal life. Br Heart J 1992;68:580–585.
  6. Ruano R, Aubry MC, Dumez Y, Zugaib M, Benachi A: Predicting neonatal deaths and pulmonary hypoplasia in isolated congenital diaphragmatic hernia using the sonographic fetal lung volume-body weight ratio. Am J Roentgenol 2008;190:1216–1219.
  7. Osada H, Litsuka Y, Masuda K, Sakamoto R, Kaku K, Seki K, Sekiya S: Application of lung volume measurement by three-dimensional ultrasonography for clinical assessment of fetal lung development. J Ultrasound Med 2002;21:841–847.
  8. Duncan KR, Gowland, PA, Moore RJ, Baker PN, Johnson IR: Assessment of fetal lung growth in utero with echo-planar MR imaging. Radiology 1999;210:197–200.
  9. Rypens F, Metens T, Rocourt N, Sonigo P, Brunelle F, Quere MP, Guibaud L, Maugey Laulom B, Durand C, Avni FE, Eurin D: Fetal lung volume: estimation at MR imaging – initial results. Radiology 2001;219:236–241.
  10. Coakley FV, Lopoo JB, Lu Y, Hricak H, Albanese CT, Harrison MR, Filly RA: Normal and hypoplastic fetal lungs: volumetric assessment with prenatal single-shot rapid acquisition with relaxation enhancement MR imaging. Radiology 2000;216:107–111.
  11. Walsh DS, Hubbard AM, Olutoye OO, Howell LJ, Crombleholme TM, Floake AW, Johnson MP, Adzick NS: Assessment of fetal lung volumes and liver herniation with magnetic resonance imaging in congenital diaphragmatic hernia. Am J Obstet Gynecol 2000;183:1067–1069.
  12. Starnes VA, Pitlick PT, Bernstein D, Griffin ML, Choy M, Shumway NE: Ebstein’s anomaly appearing in the neonate: a new surgical approach. J Thorac Cardiovasc Surg 1991;101:1082–1087.
  13. Thibeault DW, Haney B: Lung volume, pulmonary vasculature, and factors affecting survival in congenital diaphragmatic hernia. Pediatrics 1998:101:289–295.
  14. Sokol J, Bohn D, Lacro RV, Ryan G, Stephens D, Rabinovitch M, Smallhorn J, Hornberger LK: Fetal pulmonary artery diameters and their association with lung hypoplasia and postnatal outcome in congenital diaphragmatic hernia. Am J Obstet Gynecol 2002;186:1085–1090.
  15. Chinoy MR: Pulmonary hypoplasia and congenital diaphragmatic hernia: advances in the pathogenetics and regulation of lung development. J Surgical Research 2002;106:209–223.
  16. Gorincour G, Bouvenot J, Mourot MG, Sonigo P, et al: Prenatal prognosis of congenital diaphragmatic hernia using magnetic resonance imaging of fetal lung volume. Ultrasound Obstet Gynecol 2005;26:738–744.
  17. Sokol J, Shimizu N, Bohn D, Doherty D, Ryan G, Hornberger K: Fetal pulmonary artery diameter measurements as a predictory of morbidity in antenatally diagnosed congenital diaphragmatic hernia: a prospective study. Am J Obstetrics Gynecol 2006;195:470–477.
  18. Suda K, Bigras JL, Bohn D, Hornberger LK, McCrindle BW: Echocardiographic predictors of outcome in newborns with congenital diaphragmatic hernia. Pediatrics 2000;105:1106–1109.
  19. Tanaka T, Yamaki S, Ohno T, Ozawa A, Kakizawa H, Linuma K: The histology of the lung in neonates with tricuspid valve disease and gross cardiomegaly due to severe regurgitation. Pediatr Cardiol 1998;19:133–138.
  20. Katayama S, Tada K, Nakanishi Y, Takata M, Kumazawa K, Tsukahara S, Takamaru E: Evaluation of normal fetal branch pulmonary artery diameters measured by ultrasonography: a comparison with congenital diaphragmatic hernia. Fetal Diagn Ther 2008;23:303–307.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50